Emcure Pharmaceuticals Ltd (EMCURE) — Financial Flexibility Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of Rs3.85 Billion (operating CF Rs2.56 Billion minus capex Rs1.29 Billion) represents 0% of total liabilities (Rs45.09 Billion). Also explore net asset momentum of Emcure Pharmaceuticals Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Emcure Pharmaceuticals Ltd Financial Flexibility Index (2022–2026)
Historical Financial Flexibility Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. Check Emcure Pharmaceuticals Ltd (EMCURE) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year free cash flow to debt coverage for Emcure Pharmaceuticals Ltd. For the full company profile including market capitalisation, see EMCURE market cap overview.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.26x | Rs12.11 Billion | Rs8.51 Billion | Rs46.36 Billion | ▼ -25.5% |
| 2025 | 0.35x | Rs12.59 Billion | Rs8.52 Billion | Rs35.91 Billion | ▲ +16.9% |
| 2024 | 0.30x | Rs14.04 Billion | Rs10.97 Billion | Rs46.84 Billion | ▲ +4.9% |
| 2023 | 0.29x | Rs11.50 Billion | Rs7.47 Billion | Rs40.23 Billion | ▼ -3.1% |
| 2022 | 0.30x | Rs11.65 Billion | Rs7.68 Billion | Rs39.49 Billion | — |